| Leslie C. Love, Ph.d., Pc | |
|
110 E Superior St Alma MI 48801-1817 | |
| (989) 466-9200 | |
| (989) 466-9200 |
| Full Name | Leslie C. Love, Ph.d., Pc |
|---|---|
| Speciality | Psychologist |
| Location | 110 E Superior St, Alma, Michigan |
| Authorized Official Name and Position | Leslie Carol Love (OWNER) |
| Authorized Official Contact | 9894669200 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Leslie C. Love, Ph.d., Pc 110 E Superior St Alma MI 48801-1817 Ph: (989) 466-9200 | Leslie C. Love, Ph.d., Pc 110 E Superior St Alma MI 48801-1817 Ph: (989) 466-9200 |
| NPI Number | 1760701270 |
|---|---|
| Provider Enumeration Date | 05/24/2010 |
| Last Update Date | 09/18/2023 |
| Certification Date | 09/18/2023 |
| Medicare PECOS PAC ID | 8729236849 |
|---|---|
| Medicare Enrollment ID | O20120914000596 |
News Archive
Elsevier announced the publication of several commentaries in the scientific journal Reproductive BioMedicine Online on the subject of how many embryos it is safe and proper to place in a uterus, and how best to regulate this decision. It is a dilemma faced by all patients anxiously caught between no pregnancies at all or facing the prospect of twins or triplets. In this difficult place it is often all too easy to think that the latter option must be the best. But is it?
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens.
Researchers at CDDEP recently published 'Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush' where they evaluated the performance of India's Mission Indradhanush (MI) child vaccination campaign - a periodic intensification of the routine immunization program.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760701270 | NPI | - | NPPES |
| 680B945060 | Other | MI | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Leslie C Love |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1669493052 PECOS PAC ID: 0345498465 Enrollment ID: I20120914000620 |
News Archive
Elsevier announced the publication of several commentaries in the scientific journal Reproductive BioMedicine Online on the subject of how many embryos it is safe and proper to place in a uterus, and how best to regulate this decision. It is a dilemma faced by all patients anxiously caught between no pregnancies at all or facing the prospect of twins or triplets. In this difficult place it is often all too easy to think that the latter option must be the best. But is it?
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens.
Researchers at CDDEP recently published 'Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush' where they evaluated the performance of India's Mission Indradhanush (MI) child vaccination campaign - a periodic intensification of the routine immunization program.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
› Verified 8 days ago
News Archive
Elsevier announced the publication of several commentaries in the scientific journal Reproductive BioMedicine Online on the subject of how many embryos it is safe and proper to place in a uterus, and how best to regulate this decision. It is a dilemma faced by all patients anxiously caught between no pregnancies at all or facing the prospect of twins or triplets. In this difficult place it is often all too easy to think that the latter option must be the best. But is it?
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens.
Researchers at CDDEP recently published 'Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush' where they evaluated the performance of India's Mission Indradhanush (MI) child vaccination campaign - a periodic intensification of the routine immunization program.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
› Verified 8 days ago
Solutions Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 223 E Superior St, Suite B, Alma, MI 48801 Phone: 989-365-2241 | |
Zenlightenment Wellness Center Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 E Superior St, Alma, MI 48801 Phone: 989-285-1818 | |
Addiction Solutions Counseling Center, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 525 N State St, Suite 5, Alma, MI 48801 Phone: 989-968-4048 | |
Firefly Learning Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 308 Gratiot Ave, Alma, MI 48801 Phone: 989-284-2154 Fax: 989-331-6550 | |
Mra Psychiatrics, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 733 W Warwick Dr Unit A, Alma, MI 48801 Phone: 989-423-0672 Fax: 989-466-6454 | |
Mymichigan Medical Center Alma Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-463-1101 | |
Mymichigan Medical Center Alma Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 315 E Warwick Dr, Suite F-1, Alma, MI 48801 Phone: 989-463-0957 Fax: 989-968-4032 |